Myc Potentiates Apoptosis by Stimulating Bax Activity at the Mitochondria
- 1 July 2001
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 21 (14) , 4725-36
- https://doi.org/10.1128/mcb.21.14.4725-4736.2001
Abstract
The ability of the c-Myc oncoprotein to potentiate apoptosis has been well documented; however, the mechanism of action remains ill defined. We have previously identified spatially distinct apoptotic pathways within the same cell that are differentially inhibited by Bcl-2 targeted to either the mitochondria (Bcl-acta) or the endoplasmic reticulum (Bcl-cb5). We show here that in Rat1 cells expressing an exogenous c-myc allele, distinct apoptotic pathways can be inhibited by Bcl-2 or Bcl-acta yet be distinguished by their sensitivity to Bcl-cb5 as either susceptible (serum withdrawal, taxol, and ceramide) or refractory (etoposide and doxorubicin). Myc expression and apoptosis were universally associated with Bcl-acta and not Bcl-cb5, suggesting that Myc acts downstream at a point common to these distinct apoptotic signaling cascades. Analysis of Rat1 c-myc null cells shows these same death stimuli induce apoptosis with characteristic features of nuclear condensation, membrane blebbing, poly (ADP-ribose) polymerase cleavage, and DNA fragmentation; however, this Myc-independent apoptosis is not inhibited by Bcl-2. During apoptosis, Bax translocation to the mitochondria occurs in the presence or absence of Myc expression. Moreover, Bax mRNA and protein expression remain unchanged in the presence or absence of Myc. However, in the absence of Myc, Bax is not activated and cytochrome c is not released into the cytoplasm. Reintroduction of Myc into the c-myc null cells restores Bax activation, cytochrome c release, and inhibition of apoptosis by Bcl-2. These results demonstrate a role for Myc in the regulation of Bax activation during apoptosis. Moreover, apoptosis that can be triggered in the absence of Myc provides evidence that signaling pathways exist which circumvent Bax activation and cytochrome c release to trigger caspase activation. Thus, Myc increases the cellular competence to die by enhancing disparate apoptotic signals at a common mitochondrial amplification step involving Bax activation and cytochrome c release.Keywords
This publication has 56 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- The Myc oncoprotein: a critical evaluation of transactivation and target gene regulationOncogene, 1999
- Bcl-2 family proteinsOncogene, 1998
- Mitochondria and ApoptosisScience, 1998
- c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cellsOncogene, 1997
- Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.Genes & Development, 1994
- Integrated control of cell proliferation and cell death by the c- myc oncogenePhilosophical Transactions Of The Royal Society B-Biological Sciences, 1994
- A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.Genes & Development, 1993
- Role for c-myc in Activation-Induced Apoptotic Cell Death in T Cell HybridomasScience, 1992
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992